Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365476
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-04-09
Brief Title:
FlexWave Trial Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb Spasticity
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Effects of Extracorporeal Shock Wave for Upper Limb Flexor Spasticity in Stroke Patients A Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Extracorporeal shock wave therapy ESWT has emerged as an effective therapeutic intervention for addressing post-stroke limb spasticity This research aims to explore the therapeutic implications of focused ESWT for wrist and finger flexor muscles in patients suffering from post-stroke upper limb spasticity
Detailed Description:
This study aimed to evaluate the effects of focused Extracorporeal Shock Wave Therapy ESWT on upper limb flexor spasticity in stroke patients Participants were randomized into two groups an experimental group receiving targeted ESWT on specific forearm flexor muscles and a control group receiving placebo treatments mimicking the shockwave therapy with treatments administered twice weekly over two weeks for a total of four sessions
The efficacy of the treatment was measured using a comprehensive set of assessment tools including range of motion hand grip strength pain levels spasticity scales functional assessments as well as measures of daily living activities ultrasound strain elastography and electromyography The outcomes were evaluated at multiple points in time before treatment and 1 4 12 and 24 weeks after the therapy concluded to assess both immediate and sustained effects of the treatment on upper limb function and spasticity in stroke survivors
The efficacy of the treatment was measured using a comprehensive set of assessment tools including range of motion hand grip strength pain levels spasticity scales functional assessments as well as measures of daily living activities ultrasound strain elastography and electromyography The outcomes were evaluated at multiple points in time before treatment and 1 4 12 and 24 weeks after the therapy concluded to assess both immediate and sustained effects of the treatment on upper limb function and spasticity in stroke survivors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None